Source: Virtual Congress 2021 – COVID - 19 risk predictions



Rating:

Share or cite this content

Citations should be made in the following way:
I. Veiga Teijeiro (Lugo, Spain), I. Guzmán Peralta (Lugo, Spain), D. Pérez Ortiz (Lugo, Spain), L. Pérez De Llano (Lugo, Spain), I. Martín Robles (Lugo, Spain), N. Blanco Cid (Lugo, Spain), D. Dacal Rivas (Lugo, Spain), R. Golpe Gómez (Lugo, Spain). Predictive factors of response to systemic corticosteroids in patients hospitalized with COVID-19 pneumoniae. 3652

Member's Comments

No comment yet.

Related content which might interest you: Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Effects of systemic steroids in patients with severe community-acquired pneumonia Source: Eur Respir J 2007; 30: 951-956 Year: 2007 Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia Source: Eur Respir J 2016; 48: 797-807 Year: 2016 Predictive factors of sequelae among Tunisian patients treated for pulmonary tuberculosis. Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018 Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Source: Eur Respir J 2013; 41: 123-130 Year: 2013 Risk factors for antibiotic re-administration in patients with pneumonia during hospitalization. Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018 Local and systemic cytokine profiles in patients with non-severe and severe community-acquired pneumonia Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Impact of host status, bacteria and antibiotic therapy on systemic inflammatory response syndrome (SIRS) development in community-acquired pneumonia (CAP) Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Comparative laboratory evaluation of systemic inflammatory respond in patients with opium drugaddiction and community-acquired pneumonia Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Systemic cytokine response in patients with community-acquired pneumonia Source: Eur Respir J 2011; 37: 1431-1438 Year: 2011 Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Inhaled drugs as risk factors for community-acquired pneumonia Source: Eur Respir J 2010; 36: 1080-1087 Year: 2010 Systemic corticosteroid for treating severe community-acquired pneumonia Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Risk factors for infections with potentially resistant pathogens in patients in a pneumological intensive-care-unit Source: Eur Respir J 2002; 20: Suppl. 38, 476s Year: 2002 Prevalence and risk factors of sepsis in very old patients with CAP Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019 Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Source: Eur Respir J 2011; 37: 36-41 Year: 2011